Insights into Ginkgo Bioworks Holdings's Upcoming Earnings

Ginkgo Bioworks Holdings (NYSE:DNA) will release its quarterly earnings report on Tuesday, 2024-11-12. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Ginkgo Bioworks Holdings to report an earnings per share (EPS) of $-2.82.

Investors in Ginkgo Bioworks Holdings are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Past Earnings Performance

The company's EPS missed by $1.20 in the last quarter, leading to a 5.46% drop in the share price on the following day.

Here's a look at Ginkgo Bioworks Holdings's past performance and the resulting price change:

Quarter

Q2 2024

Q1 2024

Q4 2023

Q3 2023

EPS Estimate

-3.2

-3.2

-4

-3.6

EPS Actual

-4.4

-3.2

-4.4

-6.4

Price Change %

-5.0%

-17.0%

-15.0%

-15.0%

Tracking Ginkgo Bioworks Holdings's Stock Performance

Shares of Ginkgo Bioworks Holdings were trading at $8.49 as of November 08. Over the last 52-week period, shares are down 85.26%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

Analyst Insights on Ginkgo Bioworks Holdings

Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Ginkgo Bioworks Holdings.

Ginkgo Bioworks Holdings has received a total of 2 ratings from analysts, with the consensus rating as Buy. With an average one-year price target of ...